Annovis Bio Inc Earnings

The next earnings date for Annovis Bio Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Annovis Bio Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-0.29

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Annovis Bio Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/12/2025	After Market	$-0.32	20.62%
05/08/2025	After Market	$-0.32	60.00%
03/27/2025	After Market	$-0.43	-115.00%
11/06/2024	Before Market	$-0.97	-83.02%
08/14/2024	After Market	$-0.32	49.21%
05/10/2024	After Market	$-0.72	10.00%
03/29/2024	After Market	$-2.24	-72.31%
11/08/2023	After Market	$-1.63	-49.54%
08/14/2023	After Market	$-1.07	6.14%
05/10/2023	After Market	$-1.19	-260.61%
03/01/2023	---	$-1.05	0.00%
11/08/2022	After Market	$-0.93	7.92%
08/08/2022	Before Market	$-1.07	-67.19%
05/04/2022	After Market	$-0.72	-24.14%
03/02/2022	After Market	$-0.75	-200.00%
11/03/2021	Before Market	$-0.35	20.45%
07/28/2021	After Market	$-0.34	8.11%
05/06/2021	Before Market	$-0.46	0.00%
03/03/2021	After Market	$-0.25	-56.25%
11/04/2020	After Market	$-0.15	0.00%
07/29/2020	Before Market	$-0.34	-126.67%
05/05/2020	After Market	$-0.10	---
03/25/2020	After Market	$-0.04	---
07/03/2019	---	$-0.03	---
05/15/2019	---	$-0.03	---

More About Annovis Bio Inc

Website

https://www.annovisbio.com

Country

USA

Full Time Employees

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

“Annovis Bio Inc Earnings” Can Refer to the Annovis Bio Inc Earnings Date

Some people say “Annovis Bio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Annovis Bio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Annovis Bio Inc Stock on the Earnings Date

If you own Annovis Bio Inc stock (ANVS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Annovis Bio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Annovis Bio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Annovis Bio Inc Earnings

You can contact us any time if you would like to ask questions about Annovis Bio Inc earnings or anything else related to the stock market.